Abstract
Patent ductus arteriosus (PDA), one of the most common disorders in newborns, is associated with many complications in premature infants such as respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD). However, the diagnosis of hemodynamically significant patent ductus arteriosus (hsPDA) is still an ongoing debate. The relationship between platelet parameters and hsPDA has been explored in many studies over the last decade, but there is still no definite conclusion. We aim to explain the relationship between platelet parameters and hsPDA through this meta-analysis. Therefore, we used PubMed, Embase, the Cochrane Library, and Web of Science databases as well as the Google Scholar to search for studies up to May 2020. Three reviewers independently screened the articles, evaluated the quality of the articles, and collected the data. The random-effects model and fixed-effects model were used to evaluate pooled results. We used the I-square (I2) test to examine heterogeneity and the funnel plot; Egger’s test and meta-regression analysis were used to test for publication bias. Influence analysis was also carried out in this study. Stata version 12.0 software was used for data analysis. Fourteen studies, which included 3330 newborns, were extracted from 986 studies. The weighted mean difference (WMD) of the platelet count was − 17.98 (p < 0.001), the platelet distribution width (PDW) was 0.27 (p = 0.266), the mean platelet volume (MPV) was 0.01 (p = 0.958), the plateletcrit (PCT) was − 0.03 (p < 0.001), and the platelet mass was − 150.10 (p = 0.001).
Conclusion: Platelet count, PCT, and platelet mass of the first 3 days of life are potentially helpful in identifying premature infants at risk of hsPDA. More prospective studies on the relationship between different degrees of thrombocytopenia and platelet function and hsPDA should be conducted.
What is Known: • Platelets are involved in the formation of thrombi during closure of the arterial duct. • The diagnosis of hsPDA by Doppler echocardiography and clinical signs is not precise enough. | |
What is New: • Preterm newborns with hsPDA in the first week of life demonstrated a significant reduction in platelet count, platelet mass, and plateletcrit in the first 3 days of life. • No significant difference was shown between hsPDA and non-hsPDA infants in platelet distribution width and mean platelet volume in the first 3 days of life. |
Similar content being viewed by others
Abbreviations
- BPD:
-
Bronchopulmonary dysplasia
- CI:
-
Confidence interval
- COXI:
-
Cyclooxygenase inhibitor
- DA:
-
Ductus arteriosus
- hsPDA:
-
Hemodynamically significant PDA
- I 2 :
-
I-square
- IVH:
-
Intraventricular hemorrhage
- MPV:
-
Mean platelet volume
- NEC:
-
Necrotizing enterocolitis
- PCT:
-
Plateletcrit
- PDA:
-
Patent ductus arteriosus
- PDGF:
-
Platelet-derived growth factor
- PDW:
-
Platelet distribution width
- PGE2 :
-
Prostaglandin E2
- PRISMA:
-
The preferred reporting items for systematic reviews and meta-analyses
- RDS:
-
Respiratory distress syndrome
- ROP:
-
Retinopathy of prematurity
- WMD:
-
Weighted mean difference
References
Hung YC, Yeh JL, Hsu JH (2018) Molecular mechanisms for regulating postnatal ductus arteriosus closure. Int J Mol Sci 19. https://doi.org/10.3390/ijms19071861
Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A (2008) Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 153:807–813. https://doi.org/10.1016/j.jpeds.2008.05.059
Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK, for the NICHD Neonatal Research Network (2001) Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107:e1. https://doi.org/10.1542/peds.107.1.e1
Echtler K, Stark K, Lorenz M, Kerstan S, Walch A, Jennen L, Rudelius M, Seidl S, Kremmer E, Emambokus NR, von Bruehl ML, Frampton J, Isermann B, Genzel-Boroviczény O, Schreiber C, Mehilli J, Kastrati A, Schwaiger M, Shivdasani RA, Massberg S (2010) Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 16:75–82. https://doi.org/10.1038/nm.2060
Bas-Suárez MP, González-Luis GE, Saavedra P, Villamor E (2014) Platelet counts in the first seven days of life and patent ductus arteriosus in preterm very low-birth-weight infants. Neonatology 106:188–194. https://doi.org/10.1159/000362432
Demir N, Peker E, Ece I, Ağengin K, Bulan KA, Tuncer O (2016) Is platelet mass a more significant indicator than platelet count of closure of patent ductus arteriosus? J Matern Neonatal Med 29:1915–1918. https://doi.org/10.3109/14767058.2015.1067296
Simon SR, Van Zogchel L, Bas-Suárez MP et al (2015) Platelet counts and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology 108:143–151. https://doi.org/10.1159/000431281
Demirel G, Yılmaz A, Vatansever B, Tastekin A (2019) Is high platelet distribution width in the first hours of life can predict hemodynamically significant patent ductus arteriosus in preterm newborns? J Matern Neonatal Med 33:2049–2053. https://doi.org/10.1080/14767058.2018.1536743
Karabulut B, Arcagök BC, Simsek A (2019) Utility of the platelet-to-lymphocyte ratio in diagnosing and predicting treatment success in preterm neonates with patent ductus arteriosus. Fetal Pediatr Pathol 0:1–10. https://doi.org/10.1080/15513815.2019.1686786
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. https://doi.org/10.1136/bmj.b2700
Temel MT, Coskun ME, Akbayram S, Demiryürek AT (2017) Association between neutrophil/lymphocyte ratio with ductus arteriosus patency in preterm newborns. Bratisl Lek Listy 118:491–494. https://doi.org/10.4149/BLL
Olukman O, Ozdemir R, Karadeniz C, Calkavur S, Mese T, Vergin C (2017) Is there a relationship between platelet parameters and patency of ductus arteriosus in preterm infants? Blood Coagul Fibrinolysis 28:8–13. https://doi.org/10.1097/MBC.0000000000000520
Du JF, Liu TT, Wu H (2016) Risk factors for patent ductus arteriosus in early preterm infants: a case-control study. Chin J Contemp Pediatr 18:15–19. https://doi.org/10.7499/j.issn.1008-8830.2016.01.004
Chen YY, Wang HP, Chang JT, Chiou YH, Huang YF, Hsieh KS, Taiwan Premature Infant Development Collaborative Study Group (2014) Perinatal factors in patent ductus arteriosus in very low-birthweight infants. Pediatr Int 56:72–76. https://doi.org/10.1111/ped.12199
Dani C, Poggi C, Fontanelli G (2012) Relationship between platelet count and volume and spontaneous and pharmacological closure of ductus arteriosus in preterm infants. Am J Perinatol 30:359–364. https://doi.org/10.1055/s-0032-1324702
Akar S, Topcuoglu S, Tuten A, Ozalkaya E, Karatepe HO, Gokmen T, Ovali F, Karatekin G (2019) Is the first postnatal platelet mass as an indicator of patent ductus arteriosus? Arch Iran Med 22:687–691
Karabulut B, Simsek A, Arcagok BC (2019) Platelets and patent ductus arteriosus: is there a any association really. Adv Cardiovasc Res 143–147. https://doi.org/10.32474/ACR.2019.02.000133
Guler Kazanci E, Buyuktiryaki M, Unsal H, Tayman C (2019) Useful platelet indices for the diagnosis and follow-up of patent ductus arteriosus. Am J Perinatol 36:1521–1527. https://doi.org/10.1055/s-0039-1688821
Özer Bekmez B, Tayman C, Büyüktiryaki M, Çetinkaya AK, Çakır U, Derme T (2018) A promising, novel index in the diagnosis and follow-up of patent ductus arteriosus: red cell distribution width-to-platelet ratio. J Clin Lab Anal 32:1–6. https://doi.org/10.1002/jcla.22616
KÜÇÜK M, BAĞCI O, İĞDE M (2018) The fate of patent ductus arteriosus is not affected by platelet count and mean platelet volume in premature infants <32 gestational weeks. Turkiye Klin Cardiovasc Sci 30:53–57. https://doi.org/10.5336/cardiosci.2018-62380
Zhong JJ, Zhang J, Zhao XQ, Yang J (2018) The predictive value of platelet associated indicators on hemodynamically significant patent ductus arteriosus in preterm infants. Chin J Neonatol 33:406–409
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z
Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27:1785–1805. https://doi.org/10.1177/0962280216669183
Raju TNK (2019) From Galen to Gross and beyond: a brief history of the enigmatic patent ductus arteriosus. J Perinatol 39:1442–1448. https://doi.org/10.1038/s41372-019-0517-4
Hou HT, Xi-Zhang, Wang J et al (2019) Altered plasma proteins released from platelets and endothelial cells are associated with human patent ductus arteriosus. J Cell Physiol 234:6842–6853. https://doi.org/10.1002/jcp.27433
Olsson KW, Larsson A, Jonzon A, Sindelar R (2018) Exploration of potential biochemical markers for persistence of patent ductus arteriosus in preterm infants at 22–27 weeks’ gestation. Pediatr Res 86:333–338. https://doi.org/10.1038/s41390-018-0182-x
Engür D, Kaynak-Türkmen M, Deveci M, Yenisey Ç (2015) Platelets and platelet-derived growth factor in closure of the ductus arteriosus. Turk J Pediatr 57:242–247
Mitra S, Chan AK, Paes BA (2017) The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis. J Matern Neonatal Med 30:127–133. https://doi.org/10.3109/14767058.2016.1163684
Sallmon H, Weber SC, Dirks J, Schiffer T, Klippstein T, Stein A, Felderhoff-Müser U, Metze B, Hansmann G, Bührer C, Cremer M, Koehne P (2018) Assciation betweeen platelet counts before and during pharmacological therapy for patent ductus arterious and treatment failure in preterm infants. Front Pediatr 6:1–7. https://doi.org/10.3389/fped.2018.00041
Kumar J, Dutta S, Sundaram V, Saini SS, Sharma RR, Varma N (2019) Platelet transfusion for PDA closure in preterm infants: a randomized controlled trial. Pediatrics 143(5):e20182565. https://doi.org/10.1542/peds.2018-2565
Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan C, Neonatal Alloimmune Thrombocytopenia Registry Group (2005) Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr Blood Cancer 45:176–183. https://doi.org/10.1002/pbc.20282
Awidi AS (1992) Delivery of infants with Glanzmann thrombasthenia and subsequent blood transfusion requirements: a follow-up of 39 patients. Am J Hematol 40:1–4. https://doi.org/10.1002/ajh.2830400102
Tvedten H, Lilliehöök I, Hillström A, Häggström J (2008) Plateletcrit is superior to platelet count for assessing platelet status in Cavalier King Charles Spaniels. Vet Clin Pathol 37:266–271. https://doi.org/10.1111/j.1939-165X.2008.00054.x
Murray NA (2002) Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Acta Paediatr Int J Paediatr Suppl 91:74–81. https://doi.org/10.1111/j.1651-2227.2002.tb02908.x
Author information
Authors and Affiliations
Contributions
RD: Provided the idea, designed the strategy, co-wrote and revised the article, completed the statistical analysis, and processed pictures and tables.
QZ and YD: Participated in the inclusion and elimination of studies, conducted the data extraction and the quality assessment, co-wrote and revised the article.
DW: Participated in the inclusion and elimination of studies, conducted the quality assessment, and verified the data.
QS: Retrieved studies, co-wrote and revised the article.
RS: RS is the guarantor of the manuscript. Participated in the improvement of the research design, co-wrote and revised the article, checked all the processes of the article.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Not applicable.
Systematic review registration
The protocol for this meta-analysis was registered in the International Prospective Register of Systematic Reviews (PROSPERO) database (Registration number CRD42020186153).
Additional information
Communicated by Daniele De Luca
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 1005 kb)
Rights and permissions
About this article
Cite this article
Ding, R., Zhang, Q., Duan, Y. et al. The relationship between platelet indices and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Eur J Pediatr 180, 699–708 (2021). https://doi.org/10.1007/s00431-020-03802-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-020-03802-5